Investigators designed a biomimetic fluorescent nanoplatform which comprises tetrakis(4-carboxyphenyl) porphyrin and curcumin encapsulated within a zeolitic imidazolate framework-8, which was coated with a mouse breast cancer cell membrane for enhanced biocompatibility and targeting, while evading immune clearance.
[ACS Applied Materials & Interfaces]
